Latest News Archive
Please select Category, Year, and then Month to display items
The University of the Free State (UFS) wishes to confirm that the following financial concessions have been made to enable students to register for the 2024 academic year:
- Students with confirmed NSFAS funding:
- Students with a confirmed National Student Financial Aid Scheme (NSFAS) funding allocation for 2024 with a debt of R20 000 and less may register fully without making any payments.
- First-time entering students (FTENS) with a confirmed NSFAS funding allocation for 2024 may register fully without any payments.
- Students with a confirmed NSFAS funding allocation for 2024 with a debt of R30 000 and less may register provisionally and pay the required fees* for provisional registration.
- South African self-paying (NON-NSFAS) students:
- SA students with a debt of up to R500 may register fully without making any payments.
- SA students with a debt of up to R30 000 may register provisionally and pay the required fees* for provisional registration.
- FTENS not on UFS funded list:
- Students who are not on the funded list but report that they have been approved on their portal must contact our
Financial Aid Offices urgently so that the university can escalate to NSFAS.
The university will have continuous engagement with the National Financial Aid Scheme (NSFAS) to resolve outstanding matters. The university’s Financial Working Group (FWG) will meet regularly to determine how it can best assist students taking into consideration the financial constraints of the university.
UFS researcher explores the future cost of cancer
2017-01-10
Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.
Photo: Charl Devenish
Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.
Cancer is on the rise
There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.
The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.
Adoption of new strategies
According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.
Efficient solutions to curb cancer mortality
The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.